Log In
Print
BCIQ
Print
Print this Print this
 

PAP-1

  Manage Alerts
Collapse Summary General Information
Company Airmid Inc.
DescriptionInhibitor of potassium channel Kv1.3 (KCNA3)
Molecular Target Potassium channel Kv1.3 (KCNA3)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today